The Company’s issued share capital consists of 97,959,622 ordinary shares with a nominal value of £0.003 each (“Ordinary Shares”), each share having equal voting rights.

The Company does not hold any Ordinary shares or treasury shares.

In accordance with AIM Rule 26, in so far as the Company is aware, the percentage of the Company’s issued share capital that is not in public hands is 59.3%.

There are no restrictions on the transfer of securities.

Corporate Presentation

View our latest Corporate Presentation

View Presentation

AIM Share Price Chart

Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.

View Share Price chart

NASDAQ Share Price Chart

Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.

View share price chart